VA launches massive study to find safer blood thinner for Veterans' heart condition
NCT ID NCT06953726
Summary
This large VA study aims to determine which of two commonly prescribed blood thinners is safer and more effective for preventing strokes in veterans with atrial fibrillation (an irregular heartbeat). The trial will compare apixaban (Eliquis) and rivaroxaban (Xarelto) in approximately 10,000 veterans over several years, tracking rates of stroke, serious bleeding, and death. All information will be collected from medical records after participants receive their first prescription.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130-4817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.